- 601. Adrenal Gland Neoplasm
- [new abnormal adrenal gland tissue that grows by excessive cellular division and proliferation more rapidly than normal and continues to grow after the stimuli that initiated the new growth cease. ( CSP )] (UMLS (NCI) C0001624) =Neoplastic Process ;
| - 651. ADT/ACK - Cancel admit/visit notification
- (UMLS (HL7) C1549126) =Health Care Activity =Event Type;
|
- 602. Adrenal Gland Neuroblastoma
- [A neuroblastoma arising from the adrenal gland. ( NCI )] (UMLS (NCI) C0559460) =Neoplastic Process
| - 652. ADT/ACK - Cancel discharge/end visit
- (UMLS (HL7) C1549128) =Health Care Activity =Event Type;
|
- 603. Adrenal Gland Protein AD-004
- [Encoded by human TAF9 Gene (TAF2G Family), 264-aa 29-kDa nuclear TBP-Associated Factor 9 is a small TFIID subunit that binds to the basal transcription factor GTFIIB as well as transcriptional activators. A component of the PCAF complex and of the STAGA transcription coactivator-HAT complex, TAF9 is a p53 coactivator and interacts with viral transactivator VP16. TAF9 and TP53 bind via TP53 N-terminal amino acids that are essential for transcription. TFIID is composed of TBP and many evolutionarily conserved TAFs, which participate in basal transcription, serve as coactivators, and function in promoter recognition or modify general transcription factors to facilitate complex assembly and transcription initiation. Multimeric protein complex TFIID binds to the core promoter to position polymerase, serves as scaffold for assembly of the transcription complex, and acts as a channel for regulatory signals. (NCI) ( NCI )] (UMLS (NCI) C0540760) =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
| - 653. ADT/ACK - Cancel patient arriving - tracking
- (UMLS (HL7) C1549147) =Health Care Activity =Event Type;
|
- 604. Adrenal Gland Tuberculosis
- (UMLS (NCI) C0152889) =Disease or Syndrome
| - 654. ADT/ACK - Cancel patient departing - tracking
- (UMLS (HL7) C1549148) =Health Care Activity =Event Type;
|
- 605. Adrenal hemorrhage of fetus or newborn
- [ ] (UMLS (ICD9CM) C0158957) =Disease or Syndrome ;
| - 655. ADT/ACK - Cancel pending admit
- (UMLS (HL7) C1549142) =Health Care Activity =Event Type;
|
- 606. Adrenal Hormone
- [Hormones made from cholesterol and protein produced by the adrenal glands and regulate electrolyte balance, blood pressure, inflammation, blood sugar balance, and immune system control. ( NCI )] (UMLS (NCI) C1445654) =Organic Chemical; Pharmacologic Substance; Hormone
| - 656. ADT/ACK - Cancel pending discharge
- (UMLS (HL7) C1549140) =Health Care Activity =Event Type;
|
- 607. adrenal hypertension
- [hypertension caused by excessive production of mineralocorticoids. ( CSP )] (UMLS (CSP) C0264641) =Disease or Syndrome =adrenal disorder;
Blood Pressure, High | - 657. ADT/ACK - Cancel pending transfer
- (UMLS (HL7) C1549141) =Health Care Activity =Event Type;
|
- 608. ADRENAL HYPOFUNCTION NEC
- [ ] (UMLS (ICD9CM) C0154205) =Disease or Syndrome
| - 658. ADT/ACK - Cancel pre-admit
- (UMLS (HL7) C1549153) =Health Care Activity =Event Type;
|
- 609. ADRENAL INCISION
- (UMLS (ICD9CM) C0193676) =Therapeutic or Preventive Procedure
| - 659. ADT/ACK - Cancel transfer
- (UMLS (HL7) C1549127) =Health Care Activity =Event Type;
|
- 610. ADRENAL LESION EXCISION
- (UMLS (ICD9CM) C0193702) =Therapeutic or Preventive Procedure
| - 660. ADT/ACK - Change alternate patient ID (for backward compatibility only)
- (UMLS (HL7) C1549163) =Health Care Activity =Event Type;
|
- 611. Adrenal Mass
- (UMLS (NCI) C0342500) =Disease or Syndrome ;
| - 661. ADT/ACK - Change alternate visit ID
- (UMLS (HL7) C1549166) =Health Care Activity =Event Type;
|
- 612. adrenal medulla
- [inner part of the adrenal gland; it synthesizes, stores and releases catecholamines. ( CSP )] (UMLS (CSP) C0001629) =Body Part, Organ, or Organ Component ;
| - 662. ADT/ACK - Change an inpatient to an outpatient
- (UMLS (HL7) C1549122) =Health Care Activity =Event Type;
|
- 613. adrenal medulla cancer
- [any new and abnormal growth of the inner part of the adrenal gland; specifically a new growth of tissue of the inner part of the adrenal gland in which the growth is uncontrolled and progressive. ( CSP )] (UMLS (CSP) C0596046) =Neoplastic Process ;
=Adrenal Gland Neoplasm;
| - 663. ADT/ACK - Change an outpatient to an inpatient
- (UMLS (HL7) C1549121) =Health Care Activity =Event Type;
|
- 614. Adrenal Medulla Carcinoma
- [A carcinoma that has spread to the adrenal medulla from an adjacent or distant anatomic site. (NCI05) ( NCI )] (UMLS (NCI) C1334717) Metastatic Carcinoma to Adrenal Medulla;
Metastatic Carcinoma to the Adrenal Medulla =Neoplastic Process | - 664. ADT/ACK - Change attending doctor
- (UMLS (HL7) C1549169) =Health Care Activity =Event Type;
|
- 615. adrenal medulla hormone
- [chemical substances having a specific regulatory effect on the activity of a certain organ or organs; secreted by the inner part of the adrenal gland. ( CSP )] (UMLS (CSP) C0301822) =Neuroreactive Substance or Biogenic Amine; Hormone =neurohormone;
=Adrenal;
(.+-.)-Noradrenaline | - 665. ADT/ACK - Change patient account number
- (UMLS (HL7) C1549164) =Health Care Activity =Event Type;
|
- 616. Adrenal Medullary Hyperplasia
- (UMLS (NCI) C1332177) =Pathologic Function
| - 666. ADT/ACK - Change patient ID (for backward compatibility only)
- (UMLS (HL7) C1549161) =Health Care Activity =Event Type;
|
- 617. ADRENAL NERVE DIVISION
- [ ] (UMLS (ICD9CM) C0196617) =Therapeutic or Preventive Procedure
| - 667. ADT/ACK - Change patient identifier list
- (UMLS (HL7) C1549162) =Health Care Activity =Event Type;
|
- 618. ADRENAL OPERATION NEC
- [ ] (UMLS (ICD9CM) C0176123) =Therapeutic or Preventive Procedure
| - 668. ADT/ACK - Change visit number
- (UMLS (HL7) C1549165) =Health Care Activity =Event Type;
|
- 619. ADRENAL REIMPLANTATION
- [ ] (UMLS (ICD9CM) C0176125) =Therapeutic or Preventive Procedure
| - 669. ADT/ACK - Delete a patient record
- (UMLS (HL7) C1549138) =Health Care Activity =Event Type;
|
- 620. ADRENAL REPAIR
- (UMLS (ICD9CM) C0193745) =Therapeutic or Preventive Procedure
| - 670. ADT/ACK - Delete person information
- (UMLS (HL7) C1549144) =Health Care Activity =Event Type;
|
- 621. Adrenal Rest Neoplasm
- [A benign, testicular or ovarian tumor, derived from adrenal embryonic rest cells. It is composed of hyperplastic adrenal cortical tissue, and it is associated with congenital adrenal hyperplasia. ( NCI )] (UMLS (NCI) C0001630) =Neoplastic Process ;
| - 671. ADT/ACK - Discharge/end visit
- (UMLS (HL7) C1549118) =Health Care Activity =Event Type;
|
- 622. Adrenal Scintigraphy
- (UMLS (NCI) C0860838) =Diagnostic Procedure
| - 672. ADT/ACK - Link patient information
- (UMLS (HL7) C1549139) =Health Care Activity =Event Type;
|
- 623. adrenal transplantation
- [transferring adrenal cells, tissues or whole glands within an individual, between individuals of the same species, or between individuals of different species. ( CSP )] (UMLS (CSP) C0596047) =Therapeutic or Preventive Procedure ;
=endocrine transplantation;
| - 673. ADT/ACK - Merge account - patient account number
- (UMLS (HL7) C1549156) =Health Care Activity =Event Type;
|
- 624. ADRENAL VESSEL LIGATION
- [ ] (UMLS (ICD9CM) C0176124) =Therapeutic or Preventive Procedure
| - 674. ADT/ACK - Merge patient information (for backward compatibility only)
- (UMLS (HL7) C1549133) =Health Care Activity =Event Type;
|
- 625. adrenalin oxidase
- [An enzyme that catalyzes the oxidative deamination of naturally occurring monoamines. It is a flavin-containing enzyme that is localized in mitochondrial membranes, whether in nerve terminals, the liver, or other organs. Monoamine oxidase is important in regulating the metabolic degradation of catecholamines and serotonin in neural or target tissues. Hepatic monoamine oxidase has a crucial defensive role in inactivating circulating monoamines or those, such as tyramine, that originate in the gut and are absorbed into the portal circulation. (From Goodman and Gilman's, The Pharmacological Basis of Therapeutics, 8th ed, p415) EC 1.4.3.4. ( MSH )] (UMLS (CSP) C0026454) =Amino Acid, Peptide, or Protein; Enzyme =amine oxidoreductase;
Enzymatic Pathway of Metabolism | - 675. ADT/ACK - Merge patient information - account number only (for backward compatibility only)
- (UMLS (HL7) C1549150) =Health Care Activity =Event Type;
|
- 626. adrenergic
- [ ] (UMLS (CSP) C0599756) =Functional Concept ;
| - 676. ADT/ACK - Merge patient information - patient ID and account number (for backward compatibility only)
- (UMLS (HL7) C1549151) =Health Care Activity =Event Type;
|
- 627. adrenergic agent
- [drugs that selectively bind to and activate adrenergic receptors or mimic the actions of adrenergic transmitters; for adrenergic antagonists, see ANTIADRENERGIC AGENT. ( CSP )] (UMLS (CSP) C0001637) =Pharmacologic Substance ;
| - 677. ADT/ACK - Merge patient information - patient ID only (for backward compatibility only)
- (UMLS (HL7) C1549149) =Health Care Activity =Event Type;
|
- 628. adrenergic agonist
- [Drugs that bind to and activate adrenergic receptors. ( MSH )] (UMLS (CSP) C0001648) =Pharmacologic Substance ;
| - 678. ADT/ACK - Merge patient _ patient identifier list
- (UMLS (HL7) C1549155) =Health Care Activity =Event Type;
|
- 629. adrenergic antagonist
- [group of drugs that bind to but do not activate adrenergic receptors; they block the actions of the endogenous adrenergic transmitters epinepherine and norepinepherine. ( CSP )] (UMLS (CSP) C0242889) =Pharmacologic Substance ;
=neuropharmacologic agent;
neurotransmitter antagonist;
Adrenergic Receptor Interactions;
=Adrenergic alpha-Antagonists;
2-[N-p'-Tolyl-N-(m'-hydroxyphenyl)aminomethyl]imidazoline;
rauwolfia alkaloid;
2,4,5-Trihydroxyphenethylamine;
beta antiadrenergic agent;
Adrenergic alpha-Antagonists;
Adrenergic beta-Antagonists | - 679. ADT/ACK - Merge person information (for backward compatibility only)
- (UMLS (HL7) C1549145) =Health Care Activity =Event Type;
|
- 630. adrenergic block
- [ ] (UMLS (CSP) C0599515) =Therapeutic or Preventive Procedure ;
| - 680. ADT/ACK - Merge person _ patient ID (for backward compatibility only)
- (UMLS (HL7) C1549154) =Health Care Activity =Event Type;
|
- 631. adrenergic receptor
- [family of G protein coupled receptors sensitive to epinephrine, norepinephrine, and their analogs, found in smooth and cardiac muscle, autonomic ganglia, brain, and elsewhere. ( CSP )] (UMLS (CSP) C0034783) =Amino Acid, Peptide, or Protein; Receptor ;
=neurotransmitter receptor;
=alpha adrenergic receptor;
beta adrenergic receptor;
| - 681. ADT/ACK - Merge visit - visit number
- (UMLS (HL7) C1549157) =Health Care Activity =Event Type;
|
- 632. Adrenocortical Suppressant
- (UMLS (NCI) C0280044) =Pharmacologic Substance
| - 682. ADT/ACK - Move account information - patient account number
- (UMLS (HL7) C1549159) =Health Care Activity =Event Type;
|
- 633. adrenodoxin
- [An iron-sulfur protein which serves as an electron carrier in enzymatic steroid hydroxylation reactions in adrenal cortex mitochondria. The electron transport system which catalyzes this reaction consists of adrenodoxin reductase, NADP, adrenodoxin, and cytochrome P-450. ( MSH )] (UMLS (CSP) C0001657) =Amino Acid, Peptide, or Protein; Biologically Active Substance
| - 683. ADT/ACK - Move patient information _ patient identifier list
- (UMLS (HL7) C1549158) =Health Care Activity =Event Type;
|
- 634. ADRENOGENITAL DISORDERS
- (UMLS (ICD9CM) C0701163) =Disease or Syndrome
| - 684. ADT/ACK - Move visit information - visit number
- (UMLS (HL7) C1549160) =Health Care Activity =Event Type;
|
- 635. adrenogenital syndrome
- [Abnormal SEX DIFFERENTIATION caused by disorders of the GONADS or the ADRENAL GLANDS, such as CONGENITAL ADRENAL HYPERPLASIA and ADRENAL CORTEX NEOPLASMS. Due to abnormal steroid biosynthesis, clinical features include VIRILISM in females; FEMINIZATION in males; or precocious sexual development in children. ( MSH )] (UMLS (CSP) C0302280) =Congenital Abnormality
| - 685. ADT/ACK - Patient arriving - tracking
- (UMLS (HL7) C1549125) =Health Care Activity =Event Type;
|
- 636. adrenoleukodystrophy
- [childhood genetic disease, transmitted as an X-linked recessive trait, characterized by diffuse abnormality of cerebral white matter and adrenal atrophy; mental deterioration progresses to dementia, aphasia, apraxia, dysarthria, and loss of vision. ( CSP )] (UMLS (CSP) C0162309) =Disease or Syndrome =adrenal disorder;
Adrenal Gland Hypofunction;
Genetic Condition;
LEUKODYSTROPHY;
Sphingolipidoses;
PEROXISOMAL DISORDERS;
Hereditary Central Nervous System Demyelinating Diseases;
| - 686. ADT/ACK - Patient departing - tracking
- (UMLS (HL7) C1549124) =Health Care Activity =Event Type;
|
- 637. adrenomedullin
- [A 52-amino acid peptide with multi-functions. It was originally isolated from PHEOCHROMOCYTOMA and ADRENAL MEDULLA but is widely distributed throughout the body including lung and kidney tissues. Besides controlling fluid-electrolyte homeostasis, adrenomedullin is a potent vasodilator and can inhibit pituitary ACTH secretion. ( MSH )] (UMLS (CSP) C0215825) =Amino Acid, Peptide, or Protein; Pharmacologic Substance ;
| - 687. ADT/ACK - Patient goes on a _leave of absence_
- (UMLS (HL7) C1549136) =Health Care Activity =Event Type;
|
- 638. adriamycin
- [ ] (UMLS (CSP) C0085752) =Organic Chemical; Pharmacologic Substance
| - 688. ADT/ACK - Patient returns from a _leave of absence_
- (UMLS (HL7) C1549137) =Health Care Activity =Event Type;
|
- 639. Adriamycin-DNA Complex
- [A complex comprised of Doxorubicin linked to DNA to enhance the topoisomerase II-mediated interaction with the DNA base pairs and reduce cardiotoxicity associated with anthracyclines. (NCI) ( NCI )] (UMLS (NCI) C0058725) =Nucleic Acid, Nucleoside, or Nucleotide; Pharmacologic Substance
| - 689. ADT/ACK - Pending admit
- (UMLS (HL7) C1549129) =Health Care Activity =Event Type;
|
- 640. Adriamycin-Prednisone-Oncovin Regimen
- [A regimen containing doxorubicin, prednisone and vincristine, used for the treatment of disseminated, childhood anaplastic large cell lymphoma (ALCL). ( NCI )] (UMLS (NCI) C0078040) =Therapeutic or Preventive Procedure ;
| - 690. ADT/ACK - Pending discharge
- (UMLS (HL7) C1549131) =Health Care Activity =Event Type;
|
- 641. Adronat
- (UMLS (NCI) C1510841) =Organophosphorus Compound; Pharmacologic Substance
| - 691. ADT/ACK - Pending transfer
- (UMLS (HL7) C1549130) =Health Care Activity =Event Type;
|
- 642. Adroyd
- (UMLS (NCI) C0733713) =Steroid; Pharmacologic Substance; Hormone
| - 692. ADT/ACK - Pre-admit a patient
- (UMLS (HL7) C1549120) =Health Care Activity =Event Type;
|
- 643. Adrucil
- (UMLS (NCI) C0699374) =Nucleic Acid, Nucleoside, or Nucleotide; Pharmacologic Substance ;
| - 693. ADT/ACK - Register a patient
- (UMLS (HL7) C1549119) =Health Care Activity =Event Type;
|
- 644. adseverin
- [ ] (UMLS (CSP) C0084484) =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
| - 694. ADT/ACK - Swap patients
- (UMLS (HL7) C1549132) =Health Care Activity =Event Type;
|
- 645. adsorption
- [adhesion in an extremely thin layer of molecules (as of gases, solutes, or liquids) to the surfaces of solid bodies or liquids with which they are in contact. ( CSP )] (UMLS (CSP) C0001674) =Laboratory Procedure ;
| - 695. ADT/ACK - Transfer a patient
- (UMLS (HL7) C1549117) =Health Care Activity =Event Type;
|
- 646. ADT message
- (UMLS (HL7) C1548012) =Idea or Concept =Message type;
| - 696. ADT/ACK - Unlink patient information
- (UMLS (HL7) C1549152) =Health Care Activity =Event Type;
|
- 647. ADT response
- (UMLS (HL7) C1548011) =Idea or Concept =Message type;
| - 697. ADT/ACK - Update patient information
- (UMLS (HL7) C1549123) =Health Care Activity =Event Type;
|
- 648. ADT/ACK - Add person information
- (UMLS (HL7) C1549143) =Health Care Activity =Event Type;
| - 698. ADT/ACK - Update person information
- (UMLS (HL7) C1549146) =Health Care Activity =Event Type;
|
- 649. ADT/ACK - Admit/visit notification
- (UMLS (HL7) C1549116) =Health Care Activity =Event Type;
| - 699. ADT/ACK _ Cancel change attending doctor
- (UMLS (HL7) C1549170) =Health Care Activity =Event Type;
|
- 650. ADT/ACK - Bed status update
- (UMLS (HL7) C1549135) =Health Care Activity =Event Type;
| - 700. ADT/ACK _ Cancel change consulting doctor
- (UMLS (HL7) C1549173) =Health Care Activity =Event Type;
|
home
